Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Short-term Investments (2019 - 2025)

Neuronetics (STIM) has disclosed Short-term Investments for 7 consecutive years, with $175000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Short-term Investments fell 69.41% to $175000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $175000.0, a 69.41% decrease, with the full-year FY2024 number at $206000.0, down 77.24% from a year prior.
  • Short-term Investments was $175000.0 for Q3 2025 at Neuronetics, down from $176000.0 in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $2.2 million in Q4 2021 to a low of $175000.0 in Q3 2025.
  • A 5-year average of $1.3 million and a median of $1.1 million in 2023 define the central range for Short-term Investments.
  • Peak YoY movement for Short-term Investments: soared 72.78% in 2021, then crashed 77.24% in 2024.
  • Neuronetics' Short-term Investments stood at $2.2 million in 2021, then plummeted by 30.03% to $1.5 million in 2022, then tumbled by 41.16% to $905000.0 in 2023, then plummeted by 77.24% to $206000.0 in 2024, then fell by 15.05% to $175000.0 in 2025.
  • Per Business Quant, the three most recent readings for STIM's Short-term Investments are $175000.0 (Q3 2025), $176000.0 (Q2 2025), and $1.0 million (Q1 2025).